معرفی
Amro Baassiri, MD/PhD, is a Postdoctoral Associate at Yale School of Medicine working in the Halene Lab within the Department of Internal Medicine, Medical Oncology and Hematology division. His research spans multiple areas of cancer biology, medical imaging, and translational oncology.
His educational background includes:
- PhD from American University of Beirut (2022)
- MD from American University of Beirut (2014)
- BS in Biology from American University of Beirut (2010)
Baassiri's research interests focus on molecular oncology, particularly chronic myeloid leukemia mechanisms using Drosophila models, cancer biomarker discovery, and medical imaging applications in breast and colorectal cancer. His work bridges basic science with clinical applications, examining both molecular mechanisms and practical diagnostic approaches. He has made significant contributions to understanding BCR-ABL oncogene signatures, exosomal biomarkers, and imaging techniques for cancer staging and detection.
His publication history reveals a strong trajectory in cancer research with emphasis on translational applications. Recent work shows increasing focus on molecular signatures in leukemia models, while maintaining consistent contributions to medical imaging research, particularly in breast cancer diagnostics. His research demonstrates interdisciplinary collaboration across hematology, oncology, and radiology disciplines.
Notable recognition includes:
- Leslie H. Warner Fellowship for Cancer Research (July 1, 2023)
Baassiri actively contributes to both laboratory research and clinical applications of oncology findings. His work in the Halene Lab involves molecular cancer research with translational implications, while his imaging studies demonstrate practical applications in cancer diagnostics. He has also contributed to medical education research, particularly regarding radiology resident training.
His laboratory work primarily occurs within the Halene Lab at Yale, which focuses on hematological malignancies and cancer biology, providing a strong foundation for his molecular oncology research.
